Related Experiment Video
Updated: Feb 4, 2026

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
Published on: December 13, 2017
Management of Refractory Angina Pectoris
Kevin Cheng1,2, Paul Sainsbury3, Michael Fisher4
1Specialist Angina Service, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Insights
Refractory angina (RA) is a growing challenge in coronary artery disease (CAD) management. This review explores current and novel therapies for RA patients, focusing on improving quality of life.
Area of Science:
- Cardiology
- Clinical Medicine
Background:
- Refractory angina (RA) is increasingly prevalent due to improved survival from coronary artery disease (CAD) and an aging population.
- RA patients suffer from chronic, uncontrolled angina-type pain despite optimal treatments, significantly impairing quality of life.
- These patients exhibit high healthcare service utilization, highlighting unmet clinical needs.
Purpose of the Study:
- To review existing therapies for refractory angina (RA).
- To discuss novel treatment strategies for RA management.
- To emphasize the multifactorial needs of RA patients and the role of specialist units.
Main Methods:
- Literature review of current and emerging therapies for refractory angina.
- Analysis of clinical challenges and patient outcomes in RA.
- Discussion of multidisciplinary care models for RA.
Main Results:
- Optimal pharmacological, interventional, and surgical therapies are often insufficient for RA symptom control.
- RA significantly impacts patient quality of life, despite comparable mortality rates to other CAD cohorts.
- Multidisciplinary specialist units are recognized as the optimal setting for managing RA patients.
Conclusions:
- Refractory angina presents a significant clinical challenge requiring comprehensive management strategies.
- Novel therapeutic approaches hold promise for improving outcomes in RA patients.
- Addressing the multifactorial needs of RA patients through specialized care is crucial.
Abstract:
With improvements in survival from coronary artery disease (CAD) and an ageing population, refractory angina (RA) is becoming an increasingly common clinical problem facing clinicians in routine clinical practice. These patients experience chronic symptoms in the context of CAD, characterised by angina-type pain, which is uncontrolled despite optimal pharmacological, interventional and surgical therapy. Although mortality rates are no worse in this cohort, patients experience a significantly impaired quality of life with disproportionately high utilisation of healthcare services. It has been increasingly recognised that the needs of RA patients are multifactorial and best provided by specialist multi-disciplinary units. In this review, we consider the variety of therapies available to clinicians in the management of RA and discuss the promise of novel treatments.
Related Concept Videos
Angina IV: Management
Angina V: Nursing Management
Angina I: Introduction
Angina II: Classification
Angina III: Clinical Manifestations and Assessment
Tonsillitis II: Management

